Drug Shortage Report for CYTOMEL
Report ID | 180924 |
Drug Identification Number | 01919466 |
Brand name | CYTOMEL |
Common or Proper name | Cytomel |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | LIOTHYRONINE |
Strength(s) | 25MCG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100's |
ATC code | H03AA |
ATC description | THYROID PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-01-27 |
Actual start date | 2023-01-26 |
Estimated end date | 2023-05-31 |
Actual end date | 2023-05-26 |
Shortage status | Resolved |
Updated date | 2023-05-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-05-30 | English | Compare |
v6 | 2023-02-16 | French | Compare |
v5 | 2023-02-16 | English | Compare |
v4 | 2023-01-27 | French | Compare |
v3 | 2023-01-27 | English | Compare |
v2 | 2023-01-12 | French | Compare |
v1 | 2023-01-12 | English | Compare |
Showing 1 to 7 of 7